Sort
16,300 grants matching “fatty liver disease”
NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE
$989Naga P. Chalasani · Indiana University Indianapolis · M01 · FY2008 · RR
The Role of MRTFA in Adipose Tissue Remodeling
$948Jean Lin · Boston University Medical Campus · F32 · FY2017 · DK
ISOPROSTANES: A MARKER OF OXIDATIVE INJURY IN NON-ALCOHOLIC FATTY LIVER DISEASE
$914Shikha Seksaria Sundaram · Northwestern University At Chicago · M01 · FY2007 · RR
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE
$883Indiana Univ-Purdue Univ At Indianapolis · M01 · FY2005 · RR
A novel role for p53 in congenital disorders of glycosylation
$869Jaime C Chu · Icahn School Of Medicine At Mount Sinai · K08 · FY2015 · DK
LIVER DISEASE AND FATTY OXIDATION DISORDERS
$847Wake Forest University Health Sciences · M01 · FY2005 · RR
TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN (TONIC)
$829Jean Molleston · Indiana University Indianapolis · M01 · FY2008 · RR
METABOLIC EFFECTS OF ANTIPSYCHOTICS IN CHILDREN
$813John W. Newcomer · Washington University · M01 · FY2007 · RR
Increased Adiposity Risk after Prenatal Alcohol Exposure
$786Robyn Marie Amos-Kroohs · Univ Of North Carolina Chapel Hill · F32 · FY2017 · AA
Role of PAT proteins in ectopic fat deposition
$750Carole A Sztalryd · University Of Maryland Baltimore · R01 · FY2009 · DK
NPC1L1 and Metabolic Diseases
$749Liqing Yu · Univ Of Maryland, College Park · R01 · FY2013 · DK
Anaplerotic and Oxidative Regulation of Hepatic Gluconeogenesis In Vivo
$729David Andrew Cappel · Ut Southwestern Medical Center · F32 · FY2017 · DK
CLINICAL TRIAL: PHASE II TRIAL OF IDB 1016 IN ADULT DIABETIC PATIENTS WITH NASH
$690Heather Patton · University Of California, San Diego · M01 · FY2010 · RR
LIPID METABOLISM BY NMR
$661Fariba M Assadi-Porter · University Of Wisconsin-Madison · P41 · FY2011 · RR
INSULIN RESISTANCE IN PATHOGENESIS OF NON ALCOHOLIC STEATOHEPATITIS
$648Virginia Commonwealth University · M01 · FY2000 · RR
Neuronal Protein Tyrosine Phosphatases in Metabolism
$636Kendra Bence · University Of Pennsylvania · R01 · FY2013 · DK
TREATMENT OF NONALCOHOLIC LIVER DISEASE IN CHILDREN (TONIC)
$610Karen F Murray · University Of Washington · M01 · FY2007 · RR
A RANDOMIZED, MASKED, CONTROLLED STUDY OF OMEGA-3 POLYUNSATURATED FATTY ACID
$609Kris Kowdley · University Of Washington · M01 · FY2007 · RR
NAFLD DATABASE
$600Ann O Scheimann · Johns Hopkins University · M01 · FY2007 · RR
NAFLD TONIC
$600Ann O Scheimann · Johns Hopkins University · M01 · FY2007 · RR
Mechanisms of differential susceptibility to nonalcoholic fatty liver disease
$553Jesse Daniel Riordan · Pacific Northwest Research Institute · F32 · FY2017 · DK
The Regulation of Lipid Droplet Biogenesis in Alcoholic Liver Disease
$553Jason Correnti · University Of Pennsylvania · F32 · FY2017 · AA
Rac1 Promotes Hepatic Stellate Accumulation/Activation in Liver Injury
$546Steve S Choi · Duke University · K08 · FY2013 · DK
Energy Sensors and the Regulation of the TCA Cycle in the Liver
$466Justin Fletcher · Ut Southwestern Medical Center · F32 · FY2017 · DK
Genetic and environmental regulation of liver fat metabolism
$358Romeo Papazyan · University Of Pennsylvania · F32 · FY2017 · DK